Insomnia Therapeutics Market Size, Share & Trends Report

Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-2-68038-213-6
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. Sales Channel
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Insomnia Therapeutics Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
Chapter 4. Insomnia Therapeutics Market: Type Business Analysis
                    4.1. Type Market Share, 2024 & 2030
                    4.2. Type Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
                    4.4. Benzodiazepines
                        4.4.1. Benzodiazepines Market, 2018 - 2030 (USD Million)
                    4.5. Nonbenzodiazepines
                        4.5.1. Nonbenzodiazepines Market, 2018 - 2030 (USD Million)
                    4.6. Antidepressants
                        4.6.1. Antidepressants Market, 2018 - 2030 (USD Million)
                    4.7. Orexin Antagonists
                        4.7.1. Orexin Antagonists Market, 2018 - 2030 (USD Million)
                    4.8. Melatonin Antagonists
                        4.8.1. Melatonin Antagonists Market, 2018 - 2030 (USD Million)
                    4.9. Others
                        4.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Insomnia Therapeutics Market: Sales Channel Business Analysis
                    5.1. Sales Channel Market Share, 2024 & 2030
                    5.2. Sales Channel Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
                    5.4. Prescription
                        5.4.1. Prescription Market, 2018 - 2030 (USD Million)
                    5.5. Over-the-Counter (OTC)
                        5.5.1. Over-the-Counter (OTC) Market, 2018 - 2030 (USD Million)
Chapter 6. Insomnia Therapeutics Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2024 & 2030
                    6.2. Regional Market Dashboard
                    6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    6.4. North America
                        6.4.1. North America Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.4.2. U.S.
                            6.4.2.1. Key Country Dynamics
                            6.4.2.2. Regulatory Framework
                            6.4.2.3. Competitive Insights
                            6.4.2.4. U.S. Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.4.3. Canada
                            6.4.3.1. Key Country Dynamics
                            6.4.3.2. Regulatory Framework
                            6.4.3.3. Competitive Insights
                            6.4.3.4. Canada Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.4.4. Mexico
                            6.4.4.1. Key Country Dynamics
                            6.4.4.2. Regulatory Framework
                            6.4.4.3. Competitive Insights
                            6.4.4.4. Mexico Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.5. Europe
                        6.5.1. Europe Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.5.2. UK
                            6.5.2.1. Key Country Dynamics
                            6.5.2.2. Regulatory Framework
                            6.5.2.3. Competitive Insights
                            6.5.2.4. UK Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.3. Germany
                            6.5.3.1. Key Country Dynamics
                            6.5.3.2. Regulatory Framework
                            6.5.3.3. Competitive Insights
                            6.5.3.4. Germany Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.4. France
                            6.5.4.1. Key Country Dynamics
                            6.5.4.2. Regulatory Framework
                            6.5.4.3. Competitive Insights
                            6.5.4.4. France Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.5. Italy
                            6.5.5.1. Key Country Dynamics
                            6.5.5.2. Regulatory Framework
                            6.5.5.3. Competitive Insights
                            6.5.5.4. Italy Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.6. Spain
                            6.5.6.1. Key Country Dynamics
                            6.5.6.2. Regulatory Framework
                            6.5.6.3. Competitive Insights
                            6.5.6.4. Spain Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.7. Norway
                            6.5.7.1. Key Country Dynamics
                            6.5.7.2. Regulatory Framework
                            6.5.7.3. Competitive Insights
                            6.5.7.4. Norway Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.8. Denmark
                            6.5.8.1. Key Country Dynamics
                            6.5.8.2. Regulatory Framework
                            6.5.8.3. Competitive Insights
                            6.5.8.4. Denmark Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.9. Sweden
                            6.5.9.1. Key Country Dynamics
                            6.5.9.2. Regulatory Framework
                            6.5.9.3. Competitive Insights
                            6.5.9.4. Sweden Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.6. Asia Pacific
                        6.6.1. Asia Pacific Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.6.2. Japan
                            6.6.2.1. Key Country Dynamics
                            6.6.2.2. Regulatory Framework
                            6.6.2.3. Competitive Insights
                            6.6.2.4. Japan Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.3. China
                            6.6.3.1. Key Country Dynamics
                            6.6.3.2. Regulatory Framework
                            6.6.3.3. Competitive Insights
                            6.6.3.4. China Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.4. India
                            6.6.4.1. Key Country Dynamics
                            6.6.4.2. Regulatory Framework
                            6.6.4.3. Competitive Insights
                            6.6.4.4. India Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.5. South Korea
                            6.6.5.1. Key Country Dynamics
                            6.6.5.2. Regulatory Framework
                            6.6.5.3. Competitive Insights
                            6.6.5.4. South Korea Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.6. Australia
                            6.6.6.1. Key Country Dynamics
                            6.6.6.2. Regulatory Framework
                            6.6.6.3. Competitive Insights
                            6.6.6.4. Australia Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.7. Thailand
                            6.6.7.1. Key Country Dynamics
                            6.6.7.2. Regulatory Framework
                            6.6.7.3. Competitive Insights
                            6.6.7.4. Thailand Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.7. Latin America
                        6.7.1. Latin America Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.7.2. Brazil
                            6.7.2.1. Key Country Dynamics
                            6.7.2.2. Regulatory Framework
                            6.7.2.3. Competitive Insights
                            6.7.2.4. Brazil Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.7.3. Argentina
                            6.7.3.1. Key Country Dynamics
                            6.7.3.2. Regulatory Framework
                            6.7.3.3. Competitive Insights
                            6.7.3.4. Argentina Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.8. MEA
                        6.8.1. MEA Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.8.2. South Africa
                            6.8.2.1. Key Country Dynamics
                            6.8.2.2. Regulatory Framework
                            6.8.2.3. Competitive Insights
                            6.8.2.4. South Africa Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.8.3. Saudi Arabia
                            6.8.3.1. Key Country Dynamics
                            6.8.3.2. Regulatory Framework
                            6.8.3.3. Competitive Insights
                            6.8.3.4. Saudi Arabia Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.8.4. UAE
                            6.8.4.1. Key Country Dynamics
                            6.8.4.2. Regulatory Framework
                            6.8.4.3. Competitive Insights
                            6.8.4.4. UAE Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.8.5. Kuwait
                            6.8.5.1. Key Country Dynamics
                            6.8.5.2. Regulatory Framework
                            6.8.5.3. Competitive Insights
                            6.8.5.4. Kuwait Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Participant Overview
                    7.2. Company Market Position Analysis
                    7.3. Company Categorization
                    7.4. Strategy Mapping
                    7.5. Company Profiles/Listing
                        7.5.1. Takeda Pharmaceutical Company Limited
                            7.5.1.1. Overview
                            7.5.1.2. Financial Performance
                            7.5.1.3. Product Benchmarking
                            7.5.1.4. Strategic Initiatives
                        7.5.2. VANDA PHARMACEUTICALS
                            7.5.2.1. Overview
                            7.5.2.2. Financial Performance
                            7.5.2.3. Product Benchmarking
                            7.5.2.4. Strategic Initiatives
                        7.5.3. Merck & Co., Inc.
                            7.5.3.1. Overview
                            7.5.3.2. Financial Performance
                            7.5.3.3. Product Benchmarking
                            7.5.3.4. Strategic Initiatives
                        7.5.4. Pfizer Inc.
                            7.5.4.1. Overview
                            7.5.4.2. Financial Performance
                            7.5.4.3. Product Benchmarking
                            7.5.4.4. Strategic Initiatives
                        7.5.5. Teva Pharmaceutical Industries Ltd.
                            7.5.5.1. Overview
                            7.5.5.2. Financial Performance
                            7.5.5.3. Product Benchmarking
                            7.5.5.4. Strategic Initiatives
                        7.5.6. Mylan N.V. (Viatris Inc.)
                            7.5.6.1. Overview
                            7.5.6.2. Financial Performance
                            7.5.6.3. Product Benchmarking
                            7.5.6.4. Strategic Initiatives
                        7.5.7. Sumitomo Pharma Co., Ltd.
                            7.5.7.1. Overview
                            7.5.7.2. Financial Performance
                            7.5.7.3. Product Benchmarking
                            7.5.7.4. Strategic Initiatives
                        7.5.8. Sanofi
                            7.5.8.1. Overview
                            7.5.8.2. Financial Performance
                            7.5.8.3. Product Benchmarking
                            7.5.8.4. Strategic Initiatives
                        7.5.9. Paratek Pharmaceuticals, Inc.
                            7.5.9.1. Overview
                            7.5.9.2. Financial Performance
                            7.5.9.3. Product Benchmarking
                            7.5.9.4. Strategic Initiatives
                        7.5.10. Ebb Therapeutics (Kryo)
                            7.5.10.1. Overview
                            7.5.10.2. Financial Performance
                            7.5.10.3. Product Benchmarking
                            7.5.10.4. Strategic Initiatives


List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global insomnia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 4. Global insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 5. Global insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 6. North America insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
Table 7. North America insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 8. North America insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 9. U.S. insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 10. U.S. Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 11. Canada insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 12. Canada insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 13. Mexico insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 14. Mexico insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 15. Europe insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
Table 16. Europe insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 17. Europe insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 18. UK insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 19. UK Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 20. Germany insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 21. Germany insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 22. France insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 23. France Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 24. Italy insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 25. Italy insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 26. Spain insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 27. Spain insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 28. Norway insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 29. Norway Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 30. Denmark insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 31. Denmark insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 32. Sweden insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 33. Sweden insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 34. Asia Pacific insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
Table 35. Asia Pacific insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 36. Asia Pacific insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 37. Japan insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 38. Japan insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 39. China insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 40. China insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 41. India insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 42. India insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 43. Australia insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 44. Australia insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 45. South Korea insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 46. South Korea insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 47. Thailand insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 48. Thailand insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 49. Latin America insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
Table 50. Latin America insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 51. Latin America insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 52. Brazil insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 53. Brazil insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 54. Argentina insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 55. Argentina insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa Insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 59. South Africa insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 60. South Africa insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 63. UAE insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 64. UAE insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
Table 65. Kuwait insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 66. Kuwait insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Insomnia therapeutics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type and sales channel outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Insomnia therapeutics market dynamics
Fig. 12 Insomnia therapeutics market: Porter’s five forces analysis
Fig. 13 Insomnia therapeutics market: PESTLE analysis
Fig. 14 Insomnia therapeutics market: Type segment dashboard
Fig. 15 Insomnia therapeutics market: Type market share analysis, 2024 & 2030
Fig. 16 Benzodiazepines market, 2018 - 2030 (USD Million)
Fig. 17 Nonbenzodiazepines market, 2018 - 2030 (USD Million)
Fig. 18 Antidepressants market, 2018 - 2030 (USD Million)
Fig. 19 Orexin antagonists market, 2018 - 2030 (USD Million)
Fig. 20 Melatonin antagonists market, 2018 - 2030 (USD Million)
Fig. 21 Others market, 2018 - 2030 (USD Million)
Fig. 22 Insomnia therapeutics market: Sales channel segment dashboard
Fig. 23 Insomnia therapeutics market: Sales channel market share analysis, 2024 & 2030
Fig. 24 Prescription market, 2018 - 2030 (USD Million)
Fig. 25 Over-the-counter (OTC) market, 2018 - 2030 (USD Million)
Fig. 26 Insomnia therapeutics market revenue, by region
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 North America insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 30 U.S. country dynamics
Fig. 31 U.S. insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 32 Canada country dynamics
Fig. 33 Canada insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 34 Mexico country dynamics
Fig. 35 Mexico insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 36 Europe insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 37 UK country dynamics
Fig. 38 UK insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 39 Germany country dynamics
Fig. 40 Germany insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 41 France country dynamics
Fig. 42 France insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 43 Italy country dynamics
Fig. 44 Italy insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 45 Spain country dynamics
Fig. 46 Spain insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 47 Norway country dynamics
Fig. 48 Norway insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 49 Sweden country dynamics
Fig. 50 Sweden insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 51 Denmark country dynamics
Fig. 52 Denmark insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 54 Japan country dynamics
Fig. 55 Japan insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 56 China country dynamics
Fig. 57 China insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 58 India country dynamics
Fig. 59 India insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 60 Australia country dynamics
Fig. 61 Australia insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 62 South Korea country dynamics
Fig. 63 South Korea insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 64 Thailand country dynamics
Fig. 65 Thailand insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 66 Latin America insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 67 Brazil country dynamics
Fig. 68 Brazil insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 69 Argentina country dynamics
Fig. 70 Argentina insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 71 MEA insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 72 South Africa country dynamics
Fig. 73 South Africa insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia country dynamics
Fig. 75 Saudi Arabia insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 76 UAE country dynamics
Fig. 77 UAE insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 78 Kuwait country dynamics
Fig. 79 Kuwait insomnia therapeutics market, 2018 - 2030 (USD Million)
Fig. 80 Company categorization
Fig. 81 Company market position analysis
Fig. 82 Strategic framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon